NCATS Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Applications for Funding Deadline: Jan. 5, 2016 Webinar: Nov. 10, 2015

The National Center for Advancing Translational Sciences (NCATS) has several open SBIR and STTR program funding opportunities designed to help advance and commercialize translational research technologies. NCATS encourages applications in these research areas of interest: drug discovery and development, diagnostics and devices, bioinformatics and information technology, and clinical research.

Register today for NCATS’ webinar on Nov. 10, 2015, 1:00 p.m. ET, co-hosted by the Coalition of State Bioscience Institutes Entrepreneurship Committee, to learn more about the following funding opportunities.

Benefits of Applying: Funding is stable, predictable, not a loan, and non-dilutive. Small businesses retain intellectual property rights, and awardees also are eligible to access other support programs designed to help small businesses commercialize their technologies.

Current Funding Opportunities

All have an application deadline of Jan. 5, 2016, 5:00 p.m. local time: 

 

2015 Omnibus Solicitation

Small businesses, research and technology transfer organizations are eligible to apply for the 2015 Omnibus Solicitation. Applications may address any stage of translation, from target validation through pre-clinical and clinical evaluation to intervention, implementation and dissemination.

 

SBIR Direct to Phase II

Small businesses that have accomplished the objectives of a Phase I SBIR grant through non-SBIR funds are able to apply for SBIR direct to Phase II funding. Applicants must demonstrate the scientific and technical merit and feasibility of the prototype stage of developing a biomedical technology that has commercial potential.

  • PAR-15-288: Direct Phase II SBIR Grants to Support Extended Development, Hardening, and Dissemination of Technologies in Biomedical Computing, Informatics, and Big Data Science
  • PAR-14-088: Direct Phase II SBIR Grants to Support Biomedical Technology Development

 

Platform Delivery Technologies for Nucleic Acid Therapeutics

This funding opportunity is designed to incentivize small businesses to generate new technologies and products for delivering nucleic acids into cells and tissues for the purpose of treatment or prevention of human disease.

 

Development of Appropriate Pediatric Formulations and Drug Delivery Systems

Applications must address different and complementary research needs for the development of appropriate pediatric drug formulations in different age groups.

Learn more at NCATS Small Business, including eligibility requirements and research priorities. Contact NCATS SBIR and STTR today to discuss your project idea.

Connect with us! Like NCATS on Facebook and follow us on Twitter. Use #NCATSsbir to join the conversation.

 

***

NCATS’ SBIR and STTR programs are engines of innovation for developing and commercializing tools, technologies and intervention platforms to support the creation of new therapeutics and diagnostics. SBIR and STTR are government set-aside programs for domestic small businesses to engage in research and development that has the potential for commercialization and public benefit.

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s


%d bloggers like this: